Catalent (CTLT) Tops Q4 EPS by 7c, Revenues Miss; Offers FY19 Revenue Outlook Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results
August 28, 2018 7:30 AM EDTQ4'18 revenue of $685.3 million increased 11% as-reported, or 9% in constant currency from the prior-year period. Full-year revenue of $2,463.4 million increased 19% as-reported, or 16% in constant currency from the prior-year. Closed the acquisition of Juniper Pharmaceuticals, a European early development Center of Excellence with dose form development and clinical manufacturing capabilities. Issued 11,431,411 shares of common stock at a price to the public of $40.24, raising approximately $445 million of net proceeds used to pay down USD Term Loan floating-rate debt.... More
